DE3232830C2 - Arzneimittel - Google Patents

Arzneimittel

Info

Publication number
DE3232830C2
DE3232830C2 DE3232830A DE3232830A DE3232830C2 DE 3232830 C2 DE3232830 C2 DE 3232830C2 DE 3232830 A DE3232830 A DE 3232830A DE 3232830 A DE3232830 A DE 3232830A DE 3232830 C2 DE3232830 C2 DE 3232830C2
Authority
DE
Germany
Prior art keywords
ranitidine
medicament according
indomethacin
inflammatory
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3232830A
Other languages
German (de)
English (en)
Other versions
DE3232830A1 (de
Inventor
Alan Sinclair Marriott
Andrew Roland Mackenzie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE3232830A1 publication Critical patent/DE3232830A1/de
Application granted granted Critical
Publication of DE3232830C2 publication Critical patent/DE3232830C2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE3232830A 1981-09-04 1982-09-03 Arzneimittel Expired - Lifetime DE3232830C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8126786 1981-09-04

Publications (2)

Publication Number Publication Date
DE3232830A1 DE3232830A1 (de) 1983-03-24
DE3232830C2 true DE3232830C2 (de) 1994-12-08

Family

ID=10524316

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3232830A Expired - Lifetime DE3232830C2 (de) 1981-09-04 1982-09-03 Arzneimittel

Country Status (15)

Country Link
JP (1) JPS5865215A (it)
AU (1) AU564018B2 (it)
BE (1) BE894285A (it)
CH (1) CH652304A5 (it)
DE (1) DE3232830C2 (it)
FR (1) FR2512342B1 (it)
HK (1) HK91387A (it)
IE (1) IE54149B1 (it)
IT (1) IT1208432B (it)
KE (1) KE3739A (it)
MY (1) MY8700560A (it)
NL (1) NL193821C (it)
SE (1) SE8205034L (it)
SG (1) SG59387G (it)
ZA (1) ZA826477B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH01197444A (ja) * 1986-03-04 1989-08-09 Bristol Myers Co 非ステロイド系抗炎症組成物によって生じる消化管損傷に対するβ−アドレナリン作用薬とある種のヒスタミンＨ↓１−および／またはＨ↓２−受容体遮断薬との組合せの効果
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
EP1171161A1 (en) * 1999-04-19 2002-01-16 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2360306A1 (fr) * 1976-08-03 1978-03-03 Huguet Georgette Nouveaux medicaments antalgiques, antiseptiques et anti-inflammatoires
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives

Also Published As

Publication number Publication date
FR2512342B1 (fr) 1986-09-05
NL193821C (nl) 2000-12-04
JPS5865215A (ja) 1983-04-18
IE822152L (en) 1983-03-04
ZA826477B (en) 1984-04-25
CH652304A5 (fr) 1985-11-15
AU564018B2 (en) 1987-07-30
NL8203457A (nl) 1983-04-05
SE8205034D0 (sv) 1982-09-03
HK91387A (en) 1987-12-11
SE8205034L (sv) 1983-03-05
BE894285A (fr) 1983-03-02
FR2512342A1 (fr) 1983-03-11
IT8249071A0 (it) 1982-09-03
KE3739A (en) 1987-09-04
IE54149B1 (en) 1989-07-05
AU8799782A (en) 1983-03-10
SG59387G (en) 1987-10-23
IT1208432B (it) 1989-06-12
NL193821B (nl) 2000-08-01
DE3232830A1 (de) 1983-03-24
MY8700560A (en) 1987-12-31

Similar Documents

Publication Publication Date Title
DE69109286T2 (de) Pharmazeutische zusammensetzung.
EP0857064B1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
DE3650488T2 (de) Verwendung eines Tetrahydrocarbazolonderivates zur Herstellung von Arzneimitteln
AT401468B (de) Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
DE69425589T2 (de) Kombiniertes antipyretisches und analgetisches arzneimittel
EP0339420A2 (de) DHP-Retard-Zubereitung
DE69101111T2 (de) Oral anzuwendende Arzneimittel in Einzeldosisform.
DE3232830C2 (de) Arzneimittel
EP0548103B1 (de) Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
DD238920A5 (de) Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung
DE2507635C2 (it)
EP0147735B1 (de) Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE3301328A1 (de) Arzneimittel zur einleitenden bekaempfung von akuter oder chronischer, myelogener leukaemie
DE3545201A1 (de) Synergistische kombination von flupirtin und 4-acetamido-phenol
DE60100431T2 (de) Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln
WO1998058639A1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE3232831A1 (de) Arzneimittel
DE3306299C2 (it)
DE3315607A1 (de) Verwendung von albendazol in oraler verabreichungsform bei der bekaempfung von echinokokkose des menschen und arzneimittel
DE69103294T2 (de) Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten.
DE2456172C3 (de) Arzneimittel bei rheumatischen Erkrankungen
DE3433678A1 (de) Dobutamin enthaltendes praeparat zur oralen applikation
DE3511236C2 (it)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition